Table 1.
Antibodies used in study.
| Target | Company | Product number | Clone | Lot | Validation |
|---|---|---|---|---|---|
| aPKC-ι | BD Biosciences | 610207 | 41/PKCλ | 7219769 | siRNA KD validated by Western blotting this study and reference (71) |
| aPKC-ι | Atlas Antibodies | HPA026574 | N/A | 24060 | Validation statement on the manufacturer’s website |
| aPKC-ζ | Atlas Antibodies | HPA021851 | N/A | A1138749 | siRNA KD validated by Western blotting in this study and reference (20) |
| Total aPKC | Santa Cruz Biotechnologies | sc-17781 | H1 | C1122 | Knockdown validated reference (72) |
| AKT(pan) | Cell Signaling Technology | 2920 | 40D4 | 8 | None found |
| phospho Ser473 AKT | Cell Signaling Technology | 4060 | D9E | 25 | None found; in house validated with AKT inhibitor |
| Gasdermin-E | AbCam | ab215191 | EPR19859 | GR3279425 | Knockout validated by manufacturer |
| Gasdermin-E | Santa Cruz Biotechnologies | sc393162 | G-9 | K0121 | None found |
| cleaved GSDMD Asp275 | Cell Signaling Technology | 36425 | E7H9G | 3 | None found |
| β-actin | Cell Signaling Technology | 8457 | D6A8 | 7 | None found |
| β-actin | Cell Signaling Technology | 3700 | 8H10D | 18 | None found |
| Ezrin | Invitrogen | PA5-18541 | N/A | UH2820922 | None found |
| Phospho Thr567 Ezrin | Invitrogen | PA5-37763 | N/A | WA3173311 | None found |
| EEA1 | R&D Systems | MAB8047 | 871546 | CIIB030041 | None found |
| Cleaved Caspase-3 Asp175 | Cell Signaling Technology | 9661 | N/A | 47 | None found |
| E-cadherin | R&D Systems | MAB18381 | 180215 | JAT00221031 | None found |